Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$27.7 - $35.48 $198,664 - $254,462
7,172 New
7,172 $209,000
Q3 2023

Nov 14, 2023

BUY
$30.68 - $40.09 $413,443 - $540,252
13,476 New
13,476 $414,000
Q4 2022

Feb 13, 2023

BUY
$38.19 - $57.45 $474,701 - $714,103
12,430 New
12,430 $480,000
Q2 2020

Aug 14, 2020

SELL
$30.8 - $52.47 $413,336 - $704,147
-13,420 Closed
0 $0
Q1 2020

May 13, 2020

BUY
$28.4 - $50.7 $200,702 - $358,296
7,067 Added 111.24%
13,420 $450,000
Q4 2019

Feb 14, 2020

BUY
$36.31 - $46.83 $230,677 - $297,510
6,353 New
6,353 $288,000
Q3 2019

Nov 14, 2019

SELL
$35.66 - $44.99 $288,453 - $363,924
-8,089 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$36.57 - $47.97 $779,782 - $1.02 Million
-21,323 Reduced 72.5%
8,089 $352,000
Q1 2019

May 13, 2019

BUY
$36.47 - $42.17 $1.07 Million - $1.24 Million
29,412 New
29,412 $1.12 Million

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $892M
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Dynamic Technology Lab Private LTD Portfolio

Follow Dynamic Technology Lab Private LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

News

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.